Kimihiko Masui, Takashi Matsuoka, Jin Kono, Takayuki Sumiyoshi, Yuki Kita, Takeshi Sano, Takayuki Goto, Shusuke Akamatsu, Takashi Kobayashi, Atsuro Sawada. Analysis of trifecta outcomes in a single center with robot-assisted partial nephrectomy for T1b renal tumors. Asian journal of endoscopic surgery. 2023. 16. 3. 441-446
Takeshi Sano, Rihito Aizawa, Katsuhiro Ito, Kiyonao Nakamura, Takashi Ogata, Masashi Takeda, Akihiro Hamada, Takashi Matsuoka, Jin Kono, Yuki Kita, et al. Efficacy and Tolerability of Second-line Pembrolizumab With Radiation Therapy in Advanced Urothelial Carcinoma. Anticancer research. 2023. 43. 5. 2119-2126
Yusaku Moribata, Yasuhisa Kurata, Mizuho Nishio, Aki Kido, Satoshi Otani, Yuki Himoto, Naoko Nishio, Akihiro Furuta, Hiroyuki Onishi, Kimihiko Masui, et al. Automatic segmentation of bladder cancer on MRI using a convolutional neural network and reproducibility of radiomics features: a two-center study. Scientific reports. 2023. 13. 1. 628-628
Toshihiro Magaribuchi, Akihiro Hamada, Kimihiko Masui, Ryosuke Yasue, Masanao Koeda, Atsuro Sawada. Temperature Prediction Model for Advanced Renal Function Preservation in Partial Nephrectomy. HCI (4). 2023. 87-95
Mikio Sugimoto, Takuma Kato, Yoichiro Tohi, Yosuke Shimizu, Ryuji Matsumoto, Takahiro Inoue, Yutaka Takezawa, Kimihiko Masui, Hiroshi Sasaki, Hiromi Hirama, et al. Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study. BMC urology. 2022. 22. 1. 151-151